Aridis Pharmaceuticals Financials

Aridis Pharmaceuticals Stock Summary

Aridis Pharmaceuticals competes with Akari Therapeutics, Aditxt, ABVC Biopharma, Reviva Pharmaceuticals, and ZyVersa Therapeutics. Aridis Pharmaceuticals, Inc., a late-stage biopharmaceutical company, focuses on the discovery and development of targeted immunotherapy using fully human monoclonal antibodies to treat life-threatening infections. Aridis Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Los Gatos, California. Aridis Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 34 people.

Aridis Pharmaceuticals Key Financial Ratios

There are many critical financial ratios that Aridis Pharmaceuticals' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Aridis Pharmaceuticals reports annually and quarterly.

Aridis Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Aridis Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Aridis Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Aridis Pharmaceuticals competition to find correlations between indicators driving Aridis Pharmaceuticals's intrinsic value. More Info.Aridis Pharmaceuticals is rated below average in return on asset category among its peers. It is rated third in operating margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Aridis Pharmaceuticals' earnings, one of the primary drivers of an investment's value.

Aridis Pharmaceuticals Market Pulse

Along with financial statement analysis, the daily predictive indicators of Aridis Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Aridis Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Aridis Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Aridis Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Aridis Pharmaceuticals's daily price indicators and compare them against related drivers.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

If you are still planning to invest in Aridis Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aridis Pharmaceuticals' history and understand the potential risks before investing.